Global Allergy Immunotherapies Market Size, Status and Forecast 2020-2026
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
Market Analysis and Insights: Global Allergy Immunotherapies Market
In 2019, the global Allergy Immunotherapies market size was US$ 1293.8 million and it is expected to reach US$ 2459 million by the end of 2026, with a CAGR of 9.5% during 2021-2026.
Global Allergy Immunotherapies Scope and Market Size
Allergy Immunotherapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Allergy Immunotherapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Allergy Immunotherapies market is segmented into Subcutaneous Immunotherapy, Sublingual Immunotherapy, etc.
Segment by Application, the Allergy Immunotherapies market is segmented into Allergic Rhinitis, Allergic Asthma, Other, etc.
Regional and Country-level Analysis
The Allergy Immunotherapies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Allergy Immunotherapies market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Allergy Immunotherapies market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Allergy Immunotherapies business, the date to enter into the Allergy Immunotherapies market, Allergy Immunotherapies product introduction, recent developments, etc.
The major vendors include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti, etc.
This report focuses on the global Allergy Immunotherapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Allergy Immunotherapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergic Rhinitis
Allergic Asthma
Other
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Allergy Immunotherapies status, future forecast, growth opportunity, key market and key players.
To present the Allergy Immunotherapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Allergy Immunotherapies are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
Market Analysis and Insights: Global Allergy Immunotherapies Market
In 2019, the global Allergy Immunotherapies market size was US$ 1293.8 million and it is expected to reach US$ 2459 million by the end of 2026, with a CAGR of 9.5% during 2021-2026.
Global Allergy Immunotherapies Scope and Market Size
Allergy Immunotherapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Allergy Immunotherapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Allergy Immunotherapies market is segmented into Subcutaneous Immunotherapy, Sublingual Immunotherapy, etc.
Segment by Application, the Allergy Immunotherapies market is segmented into Allergic Rhinitis, Allergic Asthma, Other, etc.
Regional and Country-level Analysis
The Allergy Immunotherapies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Allergy Immunotherapies market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Allergy Immunotherapies Market Share AnalysisAllergy Immunotherapies market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Allergy Immunotherapies business, the date to enter into the Allergy Immunotherapies market, Allergy Immunotherapies product introduction, recent developments, etc.
The major vendors include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti, etc.
This report focuses on the global Allergy Immunotherapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Allergy Immunotherapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
Market segment by Type, the product can be split into
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Market segment by Application, split into
Allergic Rhinitis
Allergic Asthma
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Allergy Immunotherapies status, future forecast, growth opportunity, key market and key players.
To present the Allergy Immunotherapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Allergy Immunotherapies are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
